Elixirr International – Is This Consultancy Ready To Grow?
5 mins. to read
Mark Watson-Mitchell thinks this group is firmly on course to meet its $1 billion ambitions.
Equities
Small Cap Round-Up: Digital Developments
5 mins. to read
Mark Watson-Mitchell looks at Restore, Filtronic, CentralNic and NCC.
Small-Cap Update: One Fizzing Up and Running Out Of Gas
5 mins. to read
Mark Watson-Mitchell responds to news from two companies heading in different directions.
H&T Group – Trash or Treasure?
4 mins. to read
Mark Watson-Mitchell reckons now is the time to jump in on this pawnbroker after the price fallback of the last two weeks.
Hybridan Small Cap Feast
8 mins. to read
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
Small Cap catch-up highlighting Time Finance, TClarke and more
10 mins. to read
Mark Watson-Mitchell closes out the week with a look at a range of his favourite shares.
Pharmaceuticals and Biotech Are Due For a Rebound
6 mins. to read
Over the last year, defensive stocks have done very well relative to the broad market. Sectors including Health Care, Utilities and Consumer Staples are among the winners in a market haunted by the fear of a global recession.
Sureserve Group – Time To Reassess After Results?
3 mins. to read
Mark Watson-Mitchell believes that this firm’s strong order book, cash position and increasing profits exposes undervalued of its shares.
CentralNic – Looking Ahead To Q4 Results
5 mins. to read
Mark Watson-Mitchell explains why you shouldn’t underestimate this group’s potential as he sets a new target price.
Ad Astra: SpaceX versus Tesla
12 mins. to read
SpaceX will soon be worth more than Tesla. Elon, we still love you – despite your poor corporate governance, declares Victor Hill.